Similarly, limited tumor formation and metastasis have been observed after ASO-mediated downregulation of lncRNA-SChLAP1 (SWI/SNF Complex Antagonist Associated With Prostate Cancer 1), which is upregulated in prostate cancer (Huarte, 2015). Here, SCHLAP1 is linked to prostate cancer.